PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB)

CUSIP: 71715X203

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
10,666,413
Total 13F shares
600,392
Share change
-225,430
Total reported value
$934,269
Put/Call ratio
49%
Price per share
$1.57
Number of holders
18
Value change
-$425,788
Number of buys
1
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 71715X203?
CUSIP 71715X203 identifies PMCB - PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB) as of Q4 2024

As of 31 Dec 2024, PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 600,392 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EQUITEC PROPRIETARY MARKETS, LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, DIMENSIONAL FUND ADVISORS LP, Schonfeld Strategic Advisors LLC, NORTHERN TRUST CORP, Tower Research Capital LLC (TRC), and UBS Group AG. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.